Φορτώνει......
The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), causing the 2019 novel coronavirus disease (COVID-19), was introduced by WHO (World Health Organization) as “pandemic” in March 2020. According to WHO, thus far (23 November 2020) 58,425,681 infected cases including 1,385,218 deaths have b...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Probiotics Antimicrob Proteins |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer US
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7996120/ https://ncbi.nlm.nih.gov/pubmed/33770348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12602-021-09773-9 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|